Launch of the 2020 European Drug Report: presentation by EMCDDA Director Alexis Goosdeel

High availability across all drug types, drug production within Europe and highly potent substances are among the concerns addressed today by the EU drugs agency (EMCDDA) in its European Drug Report 2020: Trends and Developments. In its latest annual review — marking 25 years of monitoring — the agency describes the drug situation at the end of 2019, along with recent changes brought by the COVID-19 pandemic in early 2020.